Ridgetech Inc(RDGT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.88 | Insider Own | 0.41% | Shs Outstand | 3.6M | Perf Week | 48.72% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | 183.05% | Shs Float | 3.6M | Perf Month | 34.9% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 4.13% | Short Float | 4.89% | Perf Quarter | 32.12% |
| Income | -0.00B | P/S | 0.03 | EPS this Y | - | Inst Trans | 1.72% | Short Ratio | 0.49 | Perf Half Y | -18.31% |
| Sales | 0.13B | P/B | 0.03 | EPS next 5Y | - | ROA | -1.87% | Short Interest | 0.18M | Perf YTD | -99.73% |
| Book/sh | 45.96 | P/C | 0.24 | EPS past 3/5Y | 85.96% 70.07% | ROE | -3.55% | 52W High | -99.85% ($760.50) | Perf Year | -99.79% |
| Cash/sh | 4.93 | P/FCF | - | Sales past 3/5Y | -3.88% -0.15% | ROIC | -3.07% | 52W Low | 73.13% ($0.67) | Perf 3Y | -99.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 98.05% | Gross Margin | 3.6% | Volatility(W/M) | 18.14% 9.45% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | -0.1 | Sales Y/Y TTM | 10.16% | Oper. Margin | -1.41% | ATR (14) | 0.1 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 2.01 | EPS Q/Q | 96.35% | Profit Margin | -0.95% | RSI (14) | 68.91 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.31 | Sales Q/Q | 17.7% | SMA20 | 32.35% ($0.88) | Beta | -0.27 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 31.65% ($0.88) | Rel Volume | 0.15 | Prev Close | $1.11 |
| Employees | 64 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -97.85% ($53.95) | Avg Volume(3M) | 0.36M | Price | $1.16 |
| IPO | 2008/5/16 | Option/Short | No/Yes | Trades | 252 | Volume | 54,495 | Change | 4.5% |
💊 A pharmaceutical retail and distribution company headquartered in Hangzhou, China. It sells prescription drugs, over-the-counter (OTC) medicines, traditional Chinese medicine (TCM), health supplements, and medical devices through three channels: offline pharmacies, online pharmacies, and pharmaceutical wholesale. The company is listed on Nasdaq and changed its name from the former China Jo-Jo Drugstores to Ridgetech in 2024.
Over the past 1 year, on the lower side
100% below its 1-year high.
Traded less than usual. That is 15% of its average volume.
RDGT has a sound balance sheet but weak earning power
Of every $100 in sales, $1.41 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $3. Peers typically go for $266.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +64% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 4.1%.
Tap to view numbers
It ranks #5 of 5 in the industry
Based on market cap of $4M.
FAQ
What kind of company is RDGT?
RDGT belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is the market cap of RDGT?
The market cap of RDGT is approximately $4M, ranking 5,641 within its sector.
What is the 52-week high and low for RDGT?
RDGT has recorded a 52-week high of $760.50 and a low of $0.67.
